SCHEMBL27557477

SCHEMBL27557477

Cc1cc(C(=O)O)c(-c2ccc(Br)cc2)c(C(=O)O)c1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.50
MYC P01106 2/20 0.46
TTR P02766 1/20 0.46
EPRS1 P07814 2/20 0.44
CSNK2A1 P68400 1/20 0.44
NR4A1 P22736 1/20 0.44
MCL1 Q07820 1/20 0.43
CFD P00746 1/20 0.43
KDM4E B2RXH2 2/20 0.43
RXRA P19793 1/20 0.43
RXRB P28702 1/20 0.43
GLA P06280 1/20 0.43
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27636443 0.91 MYC (0.50) RXFP1MYCTTREPRS1CSNK2A1
SCHEMBL27482009 0.83 DHODH (0.52) MYCTTRCSNK2A1MCL1KDM4E
SCHEMBL27458636 0.82 TTR (0.59) TTRCSNK2A1MCL1KDM4EHTT
SCHEMBL27517441 0.81 NPC1 (0.54) MYCTTRCSNK2A1NR4A1MCL1
SCHEMBL27995052 0.81 TTR (0.46) MYCTTRCSNK2A1MCL1KDM4E
SCHEMBL27498799 0.81 DHODH (0.56) TTRCSNK2A1MCL1KDM4ERXRA
SCHEMBL27821953 0.81 KDM4E (0.52) RXFP1TTRCSNK2A1MCL1KDM4E
SCHEMBL28028683 0.81 TTR (0.46) RXFP1MYCTTRCSNK2A1NR4A1
SCHEMBL27730165 0.80 RXFP1 (0.45) RXFP1MYCTTREPRS1NR4A1
SCHEMBL27999421 0.79 HSD17B10 (0.51) RXFP1EPRS1CSNK2A1MCL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107849053-A Spiro compounds 卡利拉制药公司 2018-03-27 CN disclosed
CN-1882553-A Phenylacetic acid derivative, process for producing the same, and use ONO PHARMACEUTICAL CO (JP) 2006-12-20 CN disclosed
CN-1175256-A tetracyclic spiro compounds, process for their preparation and their use as 5HT1D receptor antagonists SMITHKLINE BEECHAM PLC (GB) 1998-03-04 CN disclosed